Shanghai Rightongene Biotechnology Co., Ltd. (688217)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
24. 12
-0.48
-1.9512%
¥
1.25B Market Cap
- P/E Ratio
0.72% Div Yield
1.25M Volume
- Eps
¥ 24.6
Previous Close Want to track 688217 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
688217 closed today lower at ¥24.12, a decrease of -1.9512% from yesterday's close, completing a monthly increase of 19.3469% or ¥3.91. Over the past 12 months, 688217 stock lost -9.1525%.
688217 is not paying dividends to its shareholders.
The last earnings report, released on Apr 26, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
688217 Chart
People also search for
Shanghai Rightongene Biotechnology Co., Ltd. (688217) FAQ
What is the stock price today?
The current price is ¥24.12.
On which exchange is it traded?
Shanghai Rightongene Biotechnology Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 688217.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.72%.
What is its market cap?
As of today, the market cap is 1.25B.
Has Shanghai Rightongene Biotechnology Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Shanghai Rightongene Biotechnology Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Ms. Hui Xiong CEO | SSE Exchange | CNE100005212 ISIN |
| CN Country | 501 Employees | 24 Oct 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Shanghai Rightongene Biotechnology Co., Ltd. is a pioneering entity founded in 2012, situated in Shanghai, China. The company is deeply entrenched in the biotechnological landscape, specializing in the nuanced field of in vitro diagnostic (IVD) products. Their operational sphere encompasses an expansive range of activities, including the vigorous research and development, production, and subsequent sale of cutting-edge IVD products. Shanghai Rightongene Biotechnology's mission is anchored in leveraging innovative biotechnology to improve diagnostic accuracy and efficacy, ultimately contributing to enhanced patient care and healthcare outcomes.
Products and Services
- Molecular Diagnostic Reagents: Rightongene has developed a comprehensive portfolio of molecular diagnostic reagents designed to offer precise and rapid detection of genetic markers associated with various diseases. These reagents play a crucial role in identifying specific DNA or RNA sequences, facilitating the early diagnosis and effective management of diseases, including genetic disorders, cancer, and infections.
- Scientific Research and Testing Services: Beyond products, Rightongene extends its expertise through specialized scientific research and testing services. These services target academia, healthcare facilities, and the pharmaceutical industry, offering advanced genetic testing and analysis. With a focus on blood diseases, solid tumors, and infectious diseases, Rightongene aids in the discovery of novel therapeutic targets and enhances the precision of existing treatment modalities.
Contact Information
Address: No. 147, Lane 1817, Shanghai, China, 201403
Phone: 86 21 3328 2601
Website: https://www.rightongene.com
